Financed by the Nanjing Yangtze Group with an investment of over 6 billion Yuan, the center offers a genome sequencing capacity of up to 500,000 people per year. A data storage center already completed will be able to store health and medical records of 80 million people.

China Bio news release, October 30, 2017